What is RKDA's earnings growth forecast for 2026-2026?
(NASDAQ: RKDA) Arcadia Biosciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.
Arcadia Biosciences's earnings in 2026 is -$10,232,000.
In 2026, RKDA is forecast to generate -$14,971,367 in earnings, with the lowest earnings forecast at -$14,384,254 and the highest earnings forecast at -$15,411,701.
What is RKDA's revenue growth forecast for 2026-2026?
(NASDAQ: RKDA) Arcadia Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Packaged Foods industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.
Arcadia Biosciences's revenue in 2026 is $5,063,000.
In 2026, RKDA is forecast to generate $47,636,167 in revenue, with the lowest revenue forecast at $45,768,082 and the highest revenue forecast at $49,037,231.
What is RKDA's forecast return on assets (ROA) for 2026-2026?
(NASDAQ: RKDA) forecast ROA is -317.46%, which is lower than the forecast US Packaged Foods industry average of 4.99%.
What is RKDA's Earnings Per Share (EPS) forecast for 2026-2026?
(NASDAQ: RKDA) Arcadia Biosciences's current Earnings Per Share (EPS) is -$4.89. In 2026, RKDA's EPS is forecast to hit -$2.47 (min: -$2.37, max: -$2.54).
What is RKDA's forecast return on equity (ROE) for 2026-2026?
(NASDAQ: RKDA) forecast ROE is -623.03%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.